‘Here to stay’: UKIPO unveils ‘interesting’ SkyKick roadmap
30 June 2025   Office aims to clamp down on bad faith applications following ‘significant judgment’ | Trademark lawyers laud pragmatic, ‘non draconian’ approach | Some flag limitations of new guidance | Brand owners urged to avoid Sky’s missteps.

Latest Features

Patents
Iti Negi, a senior patent engineer at Mercedes-Benz, outlines how in-house teams can drive a more effective, inventor-friendly patent process.
Patents
Early-stage companies can face high costs and little reward if they don’t get their IP strategy right from the start, say Graham Phero and Paul Ainsworth of Sterne Kessler.
Trademarks
The ‘double diamond’ case spotlights post-sale confusion and reins in the Court of Appeal, says Harri Berridge of HGF
Trademarks
The extent to which ‘post-sale confusion’ should be taken into account when determining infringement will be explored by the country’s highest court, explains Peter Nunn of Mishcon de Reya.
Patents
The latest patent data reveals where artificial intelligence is heading in the global tech race and explains how, and why, China is setting the pace, explains Ana Neves of Inventa.
Future of IP
When an influencer’s monochrome aesthetic ended in the quiet dismissal of a complaint, it still left unanswered questions, explains William Stroever of Cole Schotz.
Trademarks
Inter partes hearings at the UK Intellectual Property Office that last two hours are aimed at reducing delays—the trick for advocates is knowing what to leave out, explains Aaron Wood of Novagraaf.
Artificial Intelligence
It has taken 15 years to warm the pot, but with the AI opt-out plan, EU rightsholders are finally cooked, comments Kurt Van Damme of a Belgian copyright collecting society.
All features


More News

Diversity
25 June 2025   As Pride Month 2025 wraps up, it’s a crucial time to really consider the complex and ever-changing global landscape for the LGBTQ+ community, writes Rob Davey of Rob Davey Consulting.
Patents
25 June 2025   This panel brings together experts from Wolf Greenfield, BlueRock Therapeutics, BioNTech, and Generate Biomedicines to explore the evolving landscape of pharmaceutical collaborations. The discussion focuses on how partnerships can accelerate drug discovery, share risks, and pool resources in today’s complex drug development environment.
Trademarks
24 June 2025   UK Supreme Court finds post-sale confusion is a legitimate basis for infringement | Principle does not apply to dispute between Iconix and Dream Pairs over double-diamond Umbro mark | Delivers ‘strong rebuke’ to Court of Appeal after it ‘overstepped’ powers | Reaction from Umbro, Dream Pairs counsel.
Trademarks
23 June 2025   Zhejiang High People’s Court finds New Zealand apple producer’s trade dress infringed by local company | Rockit to sign strategic partnership deal with Xianfeng during PM's China visit.
Patents
23 June 2025   David Gindler of Orrick discusses the US Supreme Court’s ruling in Amgen v. Sanofi and what it means for ongoing Section 112 litigation. The session considers how the decision has been applied – and how it may continue to be applied – by the Federal Circuit, district courts, and the PTAB, with a focus on its relevance to the life sciences sector.
Patents
20 June 2025   Coke Morgan Stewart has issued a raft of decisions under new guidance intended to improve the US patent appeals board process. But it’s a divisive issue, finds Sarah Speight.
AI
20 June 2025   Getty v Stability AI raises key secondary infringement questions on whether AI models are ‘infringing articles’ l Court ruling could restrict AI models trained outside UK from being offered to UK users l AI training declarations ‘may become key for copyright compliance’.
More news